Regulation of Neurodegeneration-associated Protein Fragments by the N-degron Pathways
Abstract Among the most salient features that underpin the development of aging-related neurodegenerative disorders are the accumulation of protein aggregates and the decrease in cellular degradation capacity. Mammalian cells have evolved sophisticated quality control mechanisms to repair or eliminate the otherwise abnormal or misfolded proteins. Chaperones identify unstable or abnormal conformations in proteins and often help them regain their correct conformation. However, if repair is not an option, abnormal proteins are selectively degraded to prevent undesired interactions with other proteins or oligomerization into toxic multimeric complexes. The autophagic-lysosomal system and the ubiquitin–proteasome system mediate the selective and targeted degradation of abnormal or aberrant protein fragments. Despite an increasing understanding regarding the molecular responses that counteract the formation and clearance of dysfunctional protein aggregates, the role of N-degrons in these processes is poorly understood. Previous work demonstrated that the Arg-N-end rule degradation pathway (Arg-N-degron pathway) mediates the degradation of neurodegeneration-associated proteins, thereby regulating crucial signaling hubs that modulate the progression of neurodegenerative diseases. Herein, we discuss the functional interconnection between N-degron pathways and proteins associated with neurodegenerative disorders, including Alzheimer’s disease, amyotrophic lateral sclerosis, and Parkinson’s disease. We also highlight some future prospects related to how the molecular insights gained from these processes will help unveil novel therapeutic approaches..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
Neurotoxicity research - 40(2022), 1 vom: 18. Jan., Seite 298-318 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Eldeeb, Mohamed A. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
N-degron |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 |
|---|
| doi: |
10.1007/s12640-021-00396-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC207787029X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC207787029X | ||
| 003 | DE-627 | ||
| 005 | 20230511100444.0 | ||
| 007 | tu | ||
| 008 | 221220s2022 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12640-021-00396-0 |2 doi | |
| 035 | |a (DE-627)OLC207787029X | ||
| 035 | |a (DE-He213)s12640-021-00396-0-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Eldeeb, Mohamed A. |e verfasserin |0 (orcid)0000-0001-9671-9340 |4 aut | |
| 245 | 1 | 0 | |a Regulation of Neurodegeneration-associated Protein Fragments by the N-degron Pathways |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 | ||
| 520 | |a Abstract Among the most salient features that underpin the development of aging-related neurodegenerative disorders are the accumulation of protein aggregates and the decrease in cellular degradation capacity. Mammalian cells have evolved sophisticated quality control mechanisms to repair or eliminate the otherwise abnormal or misfolded proteins. Chaperones identify unstable or abnormal conformations in proteins and often help them regain their correct conformation. However, if repair is not an option, abnormal proteins are selectively degraded to prevent undesired interactions with other proteins or oligomerization into toxic multimeric complexes. The autophagic-lysosomal system and the ubiquitin–proteasome system mediate the selective and targeted degradation of abnormal or aberrant protein fragments. Despite an increasing understanding regarding the molecular responses that counteract the formation and clearance of dysfunctional protein aggregates, the role of N-degrons in these processes is poorly understood. Previous work demonstrated that the Arg-N-end rule degradation pathway (Arg-N-degron pathway) mediates the degradation of neurodegeneration-associated proteins, thereby regulating crucial signaling hubs that modulate the progression of neurodegenerative diseases. Herein, we discuss the functional interconnection between N-degron pathways and proteins associated with neurodegenerative disorders, including Alzheimer’s disease, amyotrophic lateral sclerosis, and Parkinson’s disease. We also highlight some future prospects related to how the molecular insights gained from these processes will help unveil novel therapeutic approaches. | ||
| 650 | 4 | |a Parkinson’s disease | |
| 650 | 4 | |a Synucleinopathies; Aβ | |
| 650 | 4 | |a Ubiquitin; Tau | |
| 650 | 4 | |a Protein degradation | |
| 650 | 4 | |a Proteasome | |
| 650 | 4 | |a N-end rule | |
| 650 | 4 | |a N-degron | |
| 650 | 4 | |a PINK1 | |
| 650 | 4 | |a Parkin | |
| 700 | 1 | |a Ragheb, Mohamed A. |4 aut | |
| 700 | 1 | |a Soliman, Marwa H. |4 aut | |
| 700 | 1 | |a Fahlman, Richard P. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurotoxicity research |d Springer US, 1999 |g 40(2022), 1 vom: 18. Jan., Seite 298-318 |w (DE-627)325490333 |w (DE-600)2036826-4 |x 1029-8428 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2022 |g number:1 |g day:18 |g month:01 |g pages:298-318 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s12640-021-00396-0 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 951 | |a AR | ||
| 952 | |d 40 |j 2022 |e 1 |b 18 |c 01 |h 298-318 | ||